Tag: STAT+

December 11, 2025

ACA Premium Spike: Senate Measures Fail to Resolve Issue

December 11, 2025

Europe’s Pharma Policy Shakeup: Enactment Advances

December 8, 2025

ASH: Positive News for Terns, Kura Leukemia Treatments

December 8, 2025

Dyne Submits New Duchenne Drug to FDA Approval

December 8, 2025

Sickle Cell Pill & Myelofibrosis Treatment Breakthrough

December 7, 2025

STAT+ Leukemia Drug Shows Remarkable Results

December 6, 2025

Freenome Plans IPO: Cancer Detection Firm Goes Public

December 6, 2025

Boehringer Ingelheim Schizophrenia App FDA Submission

December 4, 2025

STAT+: ASH Meeting & FDA’s Pazdur Insights

December 4, 2025

Tracy Beth Høeg Leads FDA Center for Drug Evaluation and Research

December 3, 2025

Mass. Primary Care Doctors Switch Hospitals – Rival Systems Compete

December 3, 2025

FDA Pazdur Retirement & US-UK Pharma Deal News

December 2, 2025

Medicare Kidney Failure Trial Ends Early

December 1, 2025

Hospital groups sue Trump administration to halt 340B pilot program

December 1, 2025

Medicare Advantage Enrollment Chaos & Rising Costs

November 28, 2025

Medicare Advantage Proposal: $13B Windfall for Insurers